fbpx
GE Announces the Successful Completion of the Open Cycle of the Azito Phase IV Power Plant, Generating Approximately 8% of Ivory Coast Current Installed Electricity CapacityRead more Eco Atlantic Acquires Additional Participating Interest in Block 3B/4B Offshore South AfricaRead more Cellulant Recognised as a Leading Payment Platform Solutions Provider in Nigeria for its Tingg PlatformRead more Binance Signs Cristiano Ronaldo for Exclusive PartnershipRead more Human Rights Volunteer Roles to Return for FIFA World Cup QatarRead more Mayor Adams Assembles National Group of Experts to Discuss Recommendations Before White House Conference on Hunger, Nutrition, and HealthRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No Transparency CopyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more White House ‘Social Media Summit’: No Facebook, No Twitter, No TransparencyRead more

New Zealand gets 1st shipment of COVID-19 oral treatment pill

show caption
AFP Photo
Print Friendly and PDF

May 02, 2022 - 09:39 AM

ANKARA (AA) – New Zealand on Thursday received the first shipment of molnupiravir, an oral pill to treat COVID-19, the country’s health minister said.

In a statement, Andrew Little said the oral pill will protect people from becoming critically ill and subsequent hospitalizations.

“Anti-virals stop people with mild COVID-19 symptoms from becoming very sick and needing to go to hospital, and because they are pills, they are easy for people to take at home,” said Little.

Molnupiravir, produced by Merck, an American pharmaceutical company, had received the approval from the US Food and Drug Administration last year.

New Zealand’s health regulatory authority also approved it for emergency use.

“We already have four medicines – Baricitinib, Ronapreve, Remdesivir and Tocilizumab – being used in hospitals, and this month another anti-viral, Paxlovid, started being used to treat people at home,” said Little.

However, he said vaccination is still the best defense against the virus.

“Adding molnupiravir into the mix means doctors have got a range of medicines to combat the worst symptoms of COVID-19 and protect people who are immunocompromised or have complex health conditions. It also helps prevent the health system from being overwhelmed,” Little said.

* Writing by Islamuddin Sajid

LMBCHEALTH.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.